Mapping Data Summary

• Symbol: Tie1
• Name: tyrosine kinase with immunoglobulin-like and EGF-like domains 1
• ID: MGI:99906
• Chromosome: 4

8 mapping experiments

Experiment Type	Details	Chromosome	Reference
CROSS	Cross Type: Backcross Mapping Panel: Kozak Skive (C58/J or NFS/N)	4	J:62456 Lyu MS, et al., Genetic mapping of six mouse peroxiredoxin genes and fourteen peroxiredoxin related sequences. Mamm Genome. 1999 Oct;10(10):1017-9
CROSS	Cross Type: Backcross Mapping Panel: Kozak FvC58 + FvSpr	4	J:62456 Lyu MS, et al., Genetic mapping of six mouse peroxiredoxin genes and fourteen peroxiredoxin related sequences. Mamm Genome. 1999 Oct;10(10):1017-9
CROSS	Cross Type: Backcross Mapping Panel: Kozak Skive	4	J:15180 Sato TN, et al., Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system [published erratum appears in Proc Natl Acad Sci U S A 1993 Dec 15;90(24):12056]. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9355-8
CROSS	Cross Type: Backcross Mapping Panel: Kozak FvC58 + FvSpr	4	J:15180 Sato TN, et al., Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system [published erratum appears in Proc Natl Acad Sci U S A 1993 Dec 15;90(24):12056]. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9355-8
CROSS	Cross Type: Backcross	4	J:33171 Wu C, et al., Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping. Mamm Genome. 1996 May;7(5):349-52
CROSS	Cross Type: Backcross Mapping Panel: Kozak Skive	4	J:33171 Wu C, et al., Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping. Mamm Genome. 1996 May;7(5):349-52
TEXT-Physical Mapping		4	J:80000 The FANTOM Consortium and The RIKEN Genome Exploration Research Group Phase I & II Team, Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature. 2002;420:563-573
TEXT-QTL		4	J:74369 Angel JM, et al., Tlag2, an N-methyl-N-nitrosourea susceptibility locus, maps to mouse chromosome 4. Mol Carcinog. 2002 Feb;33(2):105-12